Girl, 9, dies after incident in Hersheypark's wave pool
The incident occurred Thursday at The Boardwalk water park, which also includes slides and a lazy river. The Shore wave pool is 378,000 gallons, the largest in the state, and is up to 6 feet deep.
Hershey Enterainment & Resorts Company didn't give details on what happened.
"From the moment our lifeguard team recognized that a child was in distress, they performed an immediate rescue, followed by continuous, coordinated life-saving efforts by our lifeguards, on-site first responders and medical personnel," CEO John Lawn said in a message.
The girl was taken to Milton S. Hershey Medical Center, "where despite everyone's tireless efforts, the child did not recover," Lawn said. Authorities did not identify her.
In an updated statement Friday, the park said the wave pool within The Boardwalk will remain closed that day "out of respect for the family and deep appreciation of our team members who worked so valiantly in their efforts to save the life of the guest."
Ten lifeguards were dedicated to the wave pool at the time of the incident, the park said. Also, complimentary life vests were available.
On Thursday, Lawn said park employees were investigating the incident.
"The safety of our guests has always been our highest priority," he said. "In the coming days, we will conduct a thorough internal review and cooperate with authorities."
The park was founded by Milton S. Hershey in 1927 "as leisure grounds for employees of Hersehy's Chocolate Factory," according to the park's website.
The 121-acre amusement park includes 15 roller-coasters. It is open from Memorial Day to Labor Day.
"To every family who visits Hersheypark, please know this: your safety and well-being drive each decision we make," Lawn said. "We will thoroughly investigate this tragedy and honor the memory of this young guest by continuing our focus on ensuring the safety of our guests at Hershepark."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
2 hours ago
- UPI
Artificial sweetener sucralose may disrupt cancer treatment
Aug. 4 (UPI) -- Findings from a study in mice suggest that using a common artificial sweetener, sucralose, could hamper certain immunotherapy treatments in cancer patients. However, for folks reluctant to give up the ubiquitous sweetener, the same team of scientists may have found a way around the problem: Giving mice a supplement that boosts levels of the natural amino acid arginine appeared to negate the effect. "It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic," said study lead author Abby Overacre, an assistant professor of immunology at the University of Pittsburgh. "We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy," she said. Her team published its findings Wednesday in Cancer Discovery. Just how might sucralose disrupt cancer immunotherapies? These treatments include powerful "immune checkpoint inhibitor immunotherapies," such as anti-PD1. This treatment works by boosting the activity of key immune system cells called T cells. T cells need arginine to function effectively if they aim to kill cancer cells, the researchers explained. In the mouse experiments, mice bred to have cancers such as adenocarcinoma or melanoma experienced a shift in their gut microbiomes when sucralose was added to their diets. This led to a flourishing of certain gut bacteria that break down arginine, depleting levels of the amino acid. "When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly," Overacre explained in a university news release. "As a result, immunotherapy wasn't as effective in mice that were fed sucralose." Mice who'd been placed an an anti-PD1 immunotherapy but given sucralose ended up having larger tumors and poorer cancer survival versus those unexposed to sucralose, the team found. But there was a solution: When the researchers gave the mice the supplements arginine or citruline, the potency of immunotherapy returned to normal levels. Of course, experiments in mice don't always pan out in people. However, a follow-up study in cancer patients appeared to support findings observed in mice. The same research team tracked outcomes for 132 patients with either advanced melanomas or lung cancers who had received anti-PD1 immunotherapy alone or in combination with chemotherapy. "We found that sucralose impeded the effectiveness of immunotherapies across a range of cancer types, stages and treatment modalities," said study senior author Dr. Diwakar Davar. "These observations raise the possibility of designing prebiotics, such as targeted nutrient supplementation for patients who consume high levels of sucralose," said Davar, an associate professor of medicine at the university. He said a trial is planned to test the effectiveness of citrulline supplementation in reversing the detrimental effects of sucralose on cancer immunotherapy. As Davar noted, citrulline is thought to boost arginine levels more than giving arginine itself. More information Find out more about anti-PD1 therapies at the U.S. National Cancer Institute. Copyright © 2025 HealthDay. All rights reserved.
UPI
5 hours ago
- UPI
Korean scientists say they developed oral drug against COVID-19
An illustration is intended to show how CP-COV03, or Xafty, works against COVID-19 in the body. Image courtesy of Hyundai Bioscience SEOUL, Aug. 4 (UPI) -- A group of scientists, primarily from South Korean universities, has confirmed the efficacy of an oral anti-viral treatment, called CP-COV03 or Xafty, against COVID-19 after a clinical trial. If a later-stage trial is successful and the medication is approved by the Ministry of Food and Drug Safety, the drug could be available next year. Developed by Korea's biotech company Hyundai Bioscience, the drug was found to address major COVID-19 symptoms listed by the U.S. Food and Drug Administration, including cough, headache, sore throat, nausea and chills. The findings were published in the latest edition of the peer-reviewed journal Nature Communications. "We conducted a randomized, double-blind, placebo-controlled clinical trial with 300 patients to learn that CP-COV03 was effective in improving COVID-19 symptoms for more than 48 hours, with no serious adverse events," Dankook University professor Choy Jin-ho told UPI. He is one of the paper's corresponding co-authors. "Patients treated with CP-COV03 returned to usual health more quickly and had a lower risk of hospitalization compared to the control group. This shows that the drug is safe and effective in patients suffering from mild to moderate COVID-19," he said. Choy said he expects that CP-COV03 to have strong commercial potential because it was based on niclosamide, a well-known medication previously used to treat tapeworm infections. "Niclosamide's clinical use has been limited due to poor solubility and bioavailability. However, our study indicates that niclosamide-based CP-COV03 works as a safer and more effective alternative to previous COVID-19 treatments such as Paxlovid," Choy said. Hyundai Bioscience noted that the Seoul-based company would develop CP-COV03 as a versatile anti-viral treatment for a range of diseases, beyond just COVID-19. "We are prepared to produce CP-COV03 as a broad-spectrum treatment once we are authorized to do so in our target countries," Hyundai Bioscience CEO Bae Byoung-jun said in a phone interview. "To use CP-COV03 as a treatment for dengue fever, for example, we have received approval to start a seamless phase II/III clinical trial in Vietnam. We hope to launch the study this year, with the aim of bringing the drug to market next year," he said.
Yahoo
3 days ago
- Yahoo
Death of 9-year-old girl who drowned at Hersheypark ruled an accident
A Pennsylvania coroner has ruled a 9-year-old girl's drowning death at Hersheypark earlier in July an accident. "The cause of death was fresh water drowning and the manner of death was accidental," the Dauphin County coroner said in a statement, noting the child, identified by family as Sophia Subedi, did not have a medical event that led to her death. The incident occurred on Thursday, July 24 at the Boardwalk, a park attraction featuring water slides, a lazy river and a 387,000-gallon wave pool. Lifeguards responded to girl in distress There were 100 lifeguards at the Boardwalk at the time, the park said in a news release, including 10 lifeguards tasked with watching over the wave pool. Lifeguards, first responders and medics noticed the girl was in distress and began performing life-saving measures, the company's CEO, John Lawn, said in a written statement. A witness at the scene told WGAL one of the lifeguards attempted CPR on her while staff members tried to conceal the traumatic incident from parkgoers. The girl was taken to Milton S. Hershey Medical Center in Hershey, where she was pronounced deceased. It is the first confirmed guest fatality in the park's 118-year history. Girl remembered as 'kind and loving' A member of the Bhutanese Community in Harrisburg, the organization said she will be remembered as "a bright, kind and loving young girl," according to a Facebook post published Monday, July 28. "Sophia brought joy and light to everyone who knew her," the group's statement said. "Her sudden loss has left our entire community in grief." The child had been living in Harrisburg since 2022 and had recently completed the third grade. Her family moved to the area from Ohio, where she was born in 2016. Her funeral service is scheduled to take place on Wednesday, July 30 at the Jesse H Geigle Funeral Home in Harrisburg, the group's statement said. GoFundMe set up to help family A GoFundMe page has been started to help the girl's family with funeral expenses. As of the afternoon of July 29, it has raised over $21,000 out of a $30,000 goal. Additionally, her family has said they would like to put some of the funds toward creating a meaningful tribute. Sophia had dreams of becoming a teacher and loved reading, music and painting, the page states. "We hope to turn this loss into a legacy — perhaps by supporting children's safety initiatives, advocating for awareness, or creating a small space in her name where kids and families can feel safe, loved and connected," the GoFundMe states. This article originally appeared on USA TODAY: Hersheypark death ruled an accident; family mourns 9-year-old girl
